Allen is way too naive or has far too much hubris to not see it the way the other caller saw the free option buy-in. How can he even defend his statement by not understanding the point that was made.
We should have made this analogy to understand: "go buy a winning lottery ticket with your money and after the numbers are drawn & you show me your ticket I will decide if I will buy in @ the cost of half of your previous expense to share your future profits"
Let me say it again as I said before.
TRCA has beaten INSM at every point in the time I have followed them...EVERY one. I would love to see any good news from p2 trials because I will be gone with any decent pop in the pps. I need to commit myself to learning the lesson that these guys are scientists and certainly not businessmen.
His implication was that the partner would still be assuming the risk of the FDA not approving the product, there is still risk investing after a Phase III but prior to FDA review.
But admittedly a lot less than investing prior to a PIII... Aiming4.
News 
Market Data 
Discover 
AI
